Impact of Preoperative Sarcopenia on Perioperative Complications and Functional Outcomes, and Biochemical Recurrence Following Radical Prostatectomy: Single-Institution Experience, Retrospective Cohort Study
Open Access
- 30 June 2026
- journal article
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
- Vol. 16 (2) , 313-326
Abstract
Objective: Sarcopenia is increasingly recognized as a marker of frailty and a predictor of adverse outcomes in surgical oncology. However, its role in patients undergoing radical prostatectomy (RP) for localized prostate cancer (PCa) remains unclear.Methods: We retrospectively analyzed 165 men who underwent RP between 2015 and 2025 at a single institution. Sarcopenia was assessed using preoperative CT-derived skeletal muscle index (SMI). Perioperative complications, pathological outcomes, urinary continence, erectile function, biochemical recurrence (BCR), and all-cause mortality (ACM) were com-pared between sarcopenic and non-sarcopenic patients. Statistical analyses included the Mann–Whitney U test, chi-square test, Kaplan–Meier analysis with the log-rank test, and Cox proportional hazards regression.Results: Of the cohort, 75 patients (45.5%) were sarcopenic. These patients were older (median age 69 vs. 66 years, p=0.005) and had higher comorbidity scores (CCI ≥5: 56.0% vs. 32.2%, p=0.002). Major complications (Clavien-Dindo ≥3) occurred more frequently in the sarcopenic group (10.7% vs. 1.1%, p=0.007), although no perioperative mortality was observed. Continence status at 12 months was comparable between the groups (p=0.373). IIEF-5 scores were lower in sarcopenic patients at 12 months (median, 10 vs. 12; p=0.021); however, baseline IIEF-5 scores also differed significantly between the groups. During a median follow-up of 37 months, 65 patients developed BCR and 11 died (7 sarcopenic). Cumulative incidence of biochemical recurrence was 44% at the median follow-up. Although sarcopenic patients showed a higher recurrence trend (≈65% vs. 37%), no statistically significant difference was observed (p=0.267). In Cox Regression analysis, sarcopenia did not appear to significantly predict BCR (HR 0.75, 95% CI 0.45–1.24, p=0.272).Conclusions: Preoperative sarcopenia may be associated with increased major perioperative complications and impaired erectile function following RP. However, it was not significantly associated with BCR in this cohort. Sarcopenia may primarily serve as an indicator of surgical vulnerability rather than oncological prognosis.Keywords
This publication has 36 references indexed in Scilit:
- Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 PatientsEuropean Urology Open Science, 2023
- Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7Journal of Cachexia, Sarcopenia and Muscle, 2021
- PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyClinical Genitourinary Cancer, 2019
- The Association Between Sarcopenia and Oncologic Outcomes After Radical ProstatectomyClinical Genitourinary Cancer, 2018
- The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literatureJournal of Surgical Oncology, 2015
- Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortalityCancer, 2014
- Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary UpdateEuropean Urology, 2014
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancerCancer, 2011
- Does androgen‐deprivation therapy accelerate the development of frailty in older men with prostate cancer?Cancer, 2007